carbapenems has been researched along with African Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, J; Franklin, C; Peleg, AY; Spelman, DW | 1 |
| Díaz-Antolín, P; Gutiérrez-Urbón, O; Oliver-Palomo, A; Requena-Rodríguez, MJ | 1 |
2 other study(ies) available for carbapenems and African Lymphoma
| Article | Year |
|---|---|
Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from Australia.
Topics: Adolescent; Australia; Bacterial Proteins; beta-Lactamases; Burkitt Lymphoma; Carbapenems; Female; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2004 |
[Isolation of multi-resistant carbapenemase-producing Pseudomonas aeruginosa (VIM-2) and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (SHV-2) in a perianal ulcer in a patient with hematological disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burkitt Lymphoma; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fissure in Ano; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |